reference/7307115

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7307115

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Research Support, N.I.H., Extramural\|Research Support, U.S. Gov't, Non-P.H.S.
endingPage	E828
issn	1945-7197 0021-972X
issueIdentifier	5
pageRange	E820-E828
publicationName	The Journal of clinical endocrinology and metabolism
startingPage	E820
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ee8f296566eb9f91a5126d057cc69fd1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ae705485843d5655da9fb1b69c6ba8bd http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6fb3ed79f37f9c13bd9a239c46c73ea6 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_36fcf3ac487e694c1b167130b7f79ce2 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d62f51386142d8e7576b9b70134d6e59 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e66cdb91529e70b1f0ab37a738c40997
bibliographicCitation	Dean JP, Sprenger CC, Wan J, Haugk K, Ellis WJ, Lin DW, Corman JM, Dalkin BL, Mostaghel E, Nelson PS, Cohen P, Montgomery B, Plymate SR. Response of the insulin-like growth factor (IGF) system to IGF-IR inhibition and androgen deprivation in a neoadjuvant prostate cancer trial: effects of obesity and androgen deprivation. J Clin Endocrinol Metab. 2013 May;98(5):E820–8. PMID: 23533230; PMCID: PMC4430583.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bab0cef7effae18005cc174bad9aac46 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68ea6719789d5988458ebfc1b80c2d6e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec90f85d71572f6a7e9211d4380e3196 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d08bf03834d16555394b5f04e90c569f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0ca6421311ec731331b9a78927327ff9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b539828b81e6ad811b8ed620e9e4d178 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d851700ca00a415e58cbaa60624d3a1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa98d3c8461b8abaa05d082c8b421a50 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7bcdd5953cc1e49630363965091c452f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_564f5b65e03b6143ce2f1564b7da6192 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d491a05fd0533988844f0f4b5fbb518 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8503e1fbf599dd58d01d42e396fa2f7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a8fee87dede95cb133b0cb919a0d082
date	2013-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC4430583 https://doi.org/10.1210/jc.2012-3856 https://pubmed.ncbi.nlm.nih.gov/23533230
isPartOf	https://portal.issn.org/resource/ISSN/0021-972X https://portal.issn.org/resource/ISSN/1945-7197 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4624
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Response of the Insulin-Like Growth Factor (IGF) System to IGF-IR Inhibition and Androgen Deprivation in a Neoadjuvant Prostate Cancer Trial: Effects of Obesity and Androgen Deprivation
discusses	http://id.nlm.nih.gov/mesh/M0100717 http://id.nlm.nih.gov/mesh/M0020150 http://id.nlm.nih.gov/mesh/M0011417 http://id.nlm.nih.gov/mesh/M0573552 http://id.nlm.nih.gov/mesh/M0001103 http://id.nlm.nih.gov/mesh/M0028341 http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0151653 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0021712 http://id.nlm.nih.gov/mesh/M0026217 http://id.nlm.nih.gov/mesh/M0014878 http://id.nlm.nih.gov/mesh/M0026587 http://id.nlm.nih.gov/mesh/M0001214
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D017526Q000037 http://id.nlm.nih.gov/mesh/D000726Q000627 http://id.nlm.nih.gov/mesh/D000230Q000188 http://id.nlm.nih.gov/mesh/D011471Q000188 http://id.nlm.nih.gov/mesh/D020360 http://id.nlm.nih.gov/mesh/D009765Q000150
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D013002Q000032 http://id.nlm.nih.gov/mesh/D000970Q000008 http://id.nlm.nih.gov/mesh/D000230Q000517 http://id.nlm.nih.gov/mesh/D000971Q000008 http://id.nlm.nih.gov/mesh/D012306 http://id.nlm.nih.gov/mesh/D055502 http://id.nlm.nih.gov/mesh/D009570Q000627 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000726Q000008 http://id.nlm.nih.gov/mesh/D011471Q000150 http://id.nlm.nih.gov/mesh/D015331 http://id.nlm.nih.gov/mesh/D007328Q000097 http://id.nlm.nih.gov/mesh/D000813Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000911Q000627 http://id.nlm.nih.gov/mesh/D011471Q000601 http://id.nlm.nih.gov/mesh/D000813Q000627 http://id.nlm.nih.gov/mesh/D014105Q000627 http://id.nlm.nih.gov/mesh/D017273Q000627 http://id.nlm.nih.gov/mesh/D000911Q000008 http://id.nlm.nih.gov/mesh/D017526Q000378 http://id.nlm.nih.gov/mesh/D014105Q000008 http://id.nlm.nih.gov/mesh/D000230Q000150 http://id.nlm.nih.gov/mesh/D000230Q000601 http://id.nlm.nih.gov/mesh/D011471Q000517 http://id.nlm.nih.gov/mesh/D011468 http://id.nlm.nih.gov/mesh/D014481Q000453 http://id.nlm.nih.gov/mesh/D009570Q000008 http://id.nlm.nih.gov/mesh/D007333 http://id.nlm.nih.gov/mesh/D017273Q000008 http://id.nlm.nih.gov/mesh/D061067 http://id.nlm.nih.gov/mesh/D015992 http://id.nlm.nih.gov/mesh/D018970Q000097
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2375 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b972b5d726037ca07d19472a4ac78306 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311128 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fac3e925f919e3f89ede6c1af54e37cc http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10897 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795

Total number of triples: 107.